Recombinant Mouse Receptor tyrosine-protein kinase erbB-4 (Erbb4), partial - CD BioSciences

service-banner

Recombinant Mouse Receptor tyrosine-protein kinase erbB-4 (Erbb4), partial

Recombinant Mouse Receptor tyrosine-protein kinase erbB-4 (Erbb4), partial

SPP-02342

Size Price
20 μg Online Inquiry
100 μg Online Inquiry
500 μg Online Inquiry
Target Information
Species Mus musculus
Target Name HER4/ErbB4
UniProt No. Q61527
Subcellular Location Cell membrane, Single-pass type I membrane protein
Tissue Specificity Isoform JM-A CYT-2 and isoform JM-B CYT-2 are expressed in cerebellum, cerebral cortex, spinal cord, medulla oblongata and eye, but the kidney expresses solely isoform JM-A CYT-2 and the heart solely isoform JM-B CYT-2.
Gene Abbr. Erbb4
Full Name erb-b2 receptor tyrosine kinase 4
Alias ErbB, Her, Her4, c-erbB-4
Introduction Research studies have implicated the HER/ErbB receptor tyrosine kinase family in normal development, cardiac function and cancer. HER4/ErbB4, like other family members, has four ectodomains, a single transmembrane domain and a cytoplasmic tail containing the active tyrosine kinase domain. By binding to neuregulins and/or EGF family ligands, ErbB4 forms either a homodimer or heterodimer with other ErbB family members, which results in receptor activation and signaling. ErbB4 is ubiquitously expressed with the highest expression occurring in brain and heart. The expression of ErbB4 in breast cancer, pediatric brain cancer and other types of carcinomas has been reported in research studies suggesting that ErbB4 expression is involved in both normal tissue development and carcinogenesis.
Product Details
Product Type Recombinant Protein
Storage & Handling
Storage Temp. Store at -20 °C upon receipt unless otherwise instructed.
Handling Aliquoting is necessary for mutiple use. Avoid repeated freeze-thaw cycles.

For research use only. Not intended for any clinical use. No products from CD BioSciences may be resold, modified for resale or used to manufacture commercial products without prior written approval from CD BioSciences.